FDAnews Drug Daily Bulletin
Pharmaceuticals / Commercial Operations

Federal Judge Dismisses 149 Lawsuits Over Abilify’s Side Effects

Oct. 7, 2019
A A

A federal judge in Florida has thrown out 149 lawsuits in multidistrict litigation alleging Abilify (aripiprazole) caused their compulsive behavior.

Plaintiffs in the MDL alleged that Bristol-Myers Squibb and Otsuka’s blockbuster antipsychotic drug caused uncontrollable behavior, including compulsive spending, sex and gambling, but didn’t properly warn of the side effects on its labeling.

Judge M. Casey Rodgers of the U.S. District Court for the Northern District of Florida dismissed the cases of 149 plaintiffs because they failed to comply with court directives — following a settlement — to submit documentation supporting their claims and to show they used the brand name version of Abilify.

View today's stories